SporeGen Limited is a research and experimental development company specializing in biotechnology solutions focused on enhancing plant health and agricultural yield through innovative genetic engineering techniques. Established in South Africa, the company operates from its facility at The London Bioscience Innovation Centre, NW1 0NH. Founded in 2012, SporeGen focuses primarily on developing proprietary technologies designed to improve crop resilience against disease and pests while optimizing resource efficiency within agriculture. The core of SporeGen’s business involves targeted genetic modification of key plant species through advanced breeding methodologies. Their research spans multiple areas including accelerated growth rates, enhanced nutritional value, and increased resistance to environmental stressors like drought or salinity. They offer a range of services encompassing strain development, laboratory analysis, and field trials designed to facilitate the adoption of these technologies by agricultural stakeholders. SporeGen’s international presence is currently active, with strategic partnerships exploring opportunities across Europe and North America. The company's size is estimated as a small to medium-sized enterprise, prioritizing internal research and development over large-scale manufacturing. Their key focus remains on delivering measurable improvements in plant health through biotechnological advancements.

SporeGen Limited is a research and experimental development company specializing in biotechnology solutions focused on enhancing plant health and agricultural yield through innovative genetic engineering techniques. Established in South Africa, the company operates from its facility at The London Bioscience Innovation Centre, NW1 0NH. Founded in 2012, SporeGen focuses primarily on developing proprietary technologies designed to improve crop resilience against disease and pests while optimizing resource efficiency within agriculture. The core of SporeGen’s business involves targeted genetic modification of key plant species through advanced breeding methodologies. Their research spans multiple areas including accelerated growth rates, enhanced nutritional value, and increased resistance to environmental stressors like drought or salinity. They offer a range of services encompassing strain development, laboratory analysis, and field trials designed to facilitate the adoption of these technologies by agricultural stakeholders. SporeGen’s international presence is currently active, with strategic partnerships exploring opportunities across Europe and North America. The company's size is estimated as a small to medium-sized enterprise, prioritizing internal research and development over large-scale manufacturing. Their key focus remains on delivering measurable improvements in plant health through biotechnological advancements.